| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
35,400 |
32,184 |
$2.35M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
38,615 |
35,974 |
$1.88M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,826 |
7,511 |
$583K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
8,267 |
8,157 |
$475K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,713 |
4,571 |
$316K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,140 |
3,108 |
$218K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
6,630 |
6,380 |
$155K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,379 |
2,268 |
$149K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,014 |
2,000 |
$137K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
4,036 |
3,952 |
$132K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
11,916 |
11,647 |
$130K |
| 36415 |
Collection of venous blood by venipuncture |
27,379 |
25,065 |
$93K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,272 |
3,164 |
$91K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
5,570 |
5,478 |
$85K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
981 |
958 |
$71K |
| 80061 |
Lipid panel |
4,523 |
4,453 |
$51K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
720 |
704 |
$49K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,719 |
1,664 |
$48K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,702 |
1,647 |
$47K |
| 99215 |
Prolong outpt/office vis |
401 |
392 |
$41K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
475 |
471 |
$39K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,496 |
3,374 |
$39K |
| 99188 |
|
4,854 |
4,803 |
$36K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,627 |
4,504 |
$35K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
341 |
333 |
$34K |
| 71046 |
Radiologic examination, chest; 2 views |
1,997 |
1,909 |
$33K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,034 |
4,401 |
$31K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,262 |
1,237 |
$30K |
| 92551 |
|
4,837 |
4,779 |
$29K |
| 80053 |
Comprehensive metabolic panel |
3,655 |
3,506 |
$28K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,240 |
2,173 |
$27K |
| 91320 |
|
349 |
323 |
$26K |
| X5622 |
|
2,013 |
1,986 |
$26K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,384 |
1,347 |
$25K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,632 |
3,387 |
$21K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
499 |
491 |
$20K |
| 96127 |
|
5,713 |
5,474 |
$20K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,865 |
2,656 |
$20K |
| 90686 |
|
4,790 |
4,683 |
$18K |
| 90662 |
|
482 |
452 |
$17K |
| 99000 |
|
1,274 |
1,212 |
$15K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
280 |
276 |
$14K |
| 80050 |
General health panel |
312 |
308 |
$14K |
| 90480 |
|
477 |
463 |
$13K |
| 85027 |
|
2,616 |
2,424 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
283 |
277 |
$13K |
| 0001A |
|
312 |
308 |
$13K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
862 |
844 |
$12K |
| 87081 |
|
2,494 |
2,401 |
$12K |
| 0054A |
|
301 |
297 |
$12K |
| 87210 |
|
2,447 |
2,301 |
$11K |
| 0002A |
|
258 |
257 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,433 |
1,370 |
$9K |
| 90651 |
|
545 |
534 |
$9K |
| 81001 |
|
3,482 |
3,306 |
$9K |
| 81025 |
|
1,067 |
1,027 |
$9K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
161 |
160 |
$9K |
| 86803 |
|
696 |
673 |
$8K |
| 90682 |
|
183 |
180 |
$8K |
| 0072A |
|
215 |
208 |
$8K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
424 |
415 |
$8K |
| 86780 |
|
720 |
700 |
$7K |
| 82728 |
|
638 |
618 |
$7K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
114 |
114 |
$7K |
| 82043 |
|
1,361 |
1,344 |
$7K |
| 0071A |
|
171 |
161 |
$6K |
| 99173 |
|
5,201 |
5,131 |
$6K |
| 90715 |
|
621 |
612 |
$6K |
| 92015 |
Determination of refractive state |
924 |
912 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
215 |
209 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
699 |
665 |
$5K |
| 90670 |
|
1,796 |
1,766 |
$5K |
| G0008 |
Administration of influenza virus vaccine |
682 |
627 |
$5K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
106 |
105 |
$5K |
| 99442 |
|
218 |
150 |
$5K |
| 0124A |
|
147 |
143 |
$5K |
| 0004A |
|
169 |
166 |
$5K |
| 93000 |
|
595 |
574 |
$4K |
| 0064A |
|
119 |
118 |
$4K |
| 99421 |
|
685 |
619 |
$4K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
85 |
62 |
$4K |
| 90473 |
|
351 |
347 |
$4K |
| 84439 |
|
486 |
471 |
$4K |
| 99441 |
|
259 |
143 |
$3K |
| 90750 |
|
25 |
25 |
$3K |
| 83655 |
|
361 |
347 |
$3K |
| 99397 |
|
26 |
26 |
$3K |
| 0052A |
|
66 |
66 |
$3K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
83 |
80 |
$3K |
| 87340 |
|
389 |
375 |
$3K |
| 36416 |
|
900 |
724 |
$2K |
| 87807 |
|
190 |
189 |
$2K |
| 85610 |
|
725 |
452 |
$2K |
| 80197 |
|
213 |
147 |
$2K |
| 99443 |
|
70 |
41 |
$2K |
| 87186 |
|
294 |
266 |
$2K |
| 0154A |
|
49 |
40 |
$2K |
| 82947 |
|
674 |
661 |
$2K |
| 0051A |
|
40 |
40 |
$2K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
156 |
154 |
$2K |
| 85018 |
|
889 |
871 |
$2K |
| 0082A |
|
35 |
33 |
$1K |
| 0134A |
|
35 |
34 |
$1K |
| 90656 |
|
335 |
333 |
$1K |
| 99381 |
|
12 |
12 |
$1K |
| 99384 |
|
13 |
12 |
$980.69 |
| 84703 |
|
515 |
492 |
$955.48 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
40 |
40 |
$840.83 |
| 81003 |
|
517 |
501 |
$827.89 |
| 96161 |
|
417 |
400 |
$762.40 |
| 0083A |
|
18 |
17 |
$706.97 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
248 |
231 |
$681.64 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
99 |
89 |
$578.49 |
| 82607 |
|
39 |
38 |
$558.85 |
| 90474 |
|
118 |
116 |
$539.16 |
| 0081A |
|
13 |
13 |
$525.18 |
| 74019 |
|
41 |
39 |
$461.11 |
| 84460 |
|
94 |
91 |
$430.73 |
| 86140 |
|
101 |
97 |
$362.13 |
| V2020 |
Frames, purchases |
12 |
12 |
$360.00 |
| 90734 |
|
355 |
348 |
$346.80 |
| 82248 |
|
63 |
53 |
$259.08 |
| 87088 |
|
41 |
39 |
$253.41 |
| 73610 |
|
12 |
12 |
$245.36 |
| 73630 |
|
14 |
13 |
$239.52 |
| 85652 |
|
137 |
132 |
$237.30 |
| 83550 |
|
26 |
26 |
$229.37 |
| 90716 |
|
137 |
135 |
$208.90 |
| 69209 |
|
14 |
14 |
$201.83 |
| 90707 |
|
107 |
107 |
$121.13 |
| 90698 |
|
1,194 |
1,176 |
$105.87 |
| 83721 |
|
14 |
13 |
$96.88 |
| 83690 |
|
12 |
12 |
$87.36 |
| 82565 |
|
12 |
12 |
$69.18 |
| 90744 |
|
708 |
697 |
$29.28 |
| 92341 |
|
53 |
53 |
$27.84 |
| 90677 |
|
135 |
134 |
$15.00 |
| 90697 |
|
61 |
61 |
$15.00 |
| 90680 |
|
382 |
378 |
$15.00 |
| 90696 |
|
115 |
113 |
$12.38 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
48 |
45 |
$3.21 |
| 82570 |
|
144 |
144 |
$1.26 |
| 91317 |
|
14 |
13 |
$0.02 |
| 90619 |
|
14 |
14 |
$0.00 |
| 91319 |
|
12 |
12 |
$0.00 |
| 90710 |
|
78 |
76 |
$0.00 |
| 90633 |
|
798 |
788 |
$0.00 |
| 90685 |
|
222 |
220 |
$0.00 |
| 90648 |
|
38 |
38 |
$0.00 |
| 87338 |
|
12 |
12 |
$0.00 |
| 90700 |
|
55 |
55 |
$0.00 |
| 82274 |
|
27 |
27 |
$0.00 |
| 90681 |
|
135 |
133 |
$0.00 |
| 80076 |
|
14 |
13 |
$0.00 |